Back to results

Vasoactive Peptides in Portal Pressure

Primary Purpose

Portal Hypertension

Status

Unknown status

Phase

Not Applicable

Locations

Australia

Study Type

Interventional

Intervention

Norfloxacin

About this trial

This is an interventional treatment trial for Portal Hypertension focused on measuring HVPG > 12 mmHg

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All Sexes

Inclusion Criteria: HVPG >= 12 mmHg

Sites / Locations

Alfred HospitalRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

NCT ID

NCT00163982

First Posted

September 13, 2005

Last Updated

July 25, 2007

Sponsor

Bayside Health

1. Study Identification

Unique Protocol Identification Number

NCT00163982

Brief Title

Vasoactive Peptides in Portal Pressure

Study Type

Interventional

2. Study Status

Record Verification Date

September 2005

Overall Recruitment Status

Unknown status

Study Start Date

undefined (undefined)

Primary Completion Date

undefined (undefined)

Study Completion Date

undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor

Bayside Health

4. Oversight

5. Study Description

Brief Summary

This study is looking at the detection of vasoactive peptides in portal hypertension.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Portal Hypertension

Keywords

HVPG > 12 mmHg

7. Study Design

Primary Purpose

Treatment

Study Phase

Not Applicable

Interventional Study Model

Crossover Assignment

Masking

Double

Allocation

Randomized

8. Arms, Groups, and Interventions

Intervention Type

Drug

Intervention Name(s)

Norfloxacin

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Maximum Age & Unit of Time

75 Years

Eligibility Criteria

Inclusion Criteria: HVPG >= 12 mmHg

Central Contact Person:

First Name & Middle Initial & Last Name or Official Title & Degree

William W Kemp, MBBS, FRACP

Phone

92762000

Ext

3327

w.kemp@alfred.org.au

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

William W Kemp, MBBS, FRACP

Organizational Affiliation

The Alfred

Official's Role

Principal Investigator

Facility Information:

Facility Name

Alfred Hospital

City

Melbourne

State/Province

Victoria

ZIP/Postal Code

3181

Country

Australia

Individual Site Status

Recruiting

Facility Contact:

First Name & Middle Initial & Last Name & Degree

William W Kemp, MBBS, FRACP

Phone

92762000

Ext

3327

w.kemp@alfred.org.au

12. IPD Sharing Statement

Learn more about this trial

Vasoactive Peptides in Portal Pressure

We'll reach out to this number within 24 hrs